Original Article

You have full text access to this OnlineOpen article

Timing of hepatitis C antiviral therapy in patients with advanced liver disease: A decision analysis model†‡

  1. Sammy Saab1,2,§,*,
  2. Douglas R. Hunt3,
  3. Michael A. Stone1,
  4. Amy McClune1,2,
  5. Myron J. Tong1,2,4

Article first published online: 23 MAR 2010

DOI: 10.1002/lt.22072

Issue

Liver Transplantation

Liver Transplantation

Volume 16, Issue 6, pages 748–759, June 2010

Additional Information

How to Cite

Saab, S., Hunt, D. R., Stone, M. A., McClune, A. and Tong, M. J. (2010), Timing of hepatitis C antiviral therapy in patients with advanced liver disease: A decision analysis model. Liver Transpl, 16: 748–759. doi: 10.1002/lt.22072

Author Information

  1. 1

    Departments of Medicine, University of California at Los Angeles, Los Angeles, CA

  2. 2

    Department of Surgery, University of California at Los Angeles, Los Angeles, CA

  3. 3

    Harbor-UCLA Medical Center, Torrance, CA

  4. 4

    Huntington Medical Research Institutes, Pasadena, CA

  1. §

    Telephone: 310-206-6705; FAX: 310-206-4197

*Pfleger Liver Institute, UCLA Medical Center, 200 Medical Plaza, Suite 214, Los Angeles, CA 90095

  1. †

    No author has a conflict of interest to declare with respect to the content of this study. No part of this study was funded by the pharmaceutical industry.

  2. ‡

    See Editorial on Page 697

Publication History

  1. Issue published online: 25 MAY 2010
  2. Article first published online: 23 MAR 2010
  3. Accepted manuscript online: 23 MAR 2010 12:00AM EST
  4. Manuscript Accepted: 10 MAR 2010
  5. Manuscript Received: 7 OCT 2009

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (454K)

No citations currently available for this article.

View Full Article (HTML) Get PDF (454K)